Literature DB >> 2571175

A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.

L H Gold1, C B Hubner, G F Koob.   

Abstract

Methylenedioxymethamphetamine (MDMA) is a phenylethylamine with a chemical structure that resembles both the amphetamines and mescaline and has both stimulant and perception altering properties. The stimulant properties of MDMA were assessed in photocell cages designed to measure locomotor activity in rats. MDMA, over a range of doses (2.5-10.0 mg/kg, SC) produced locomotor hyperactivity which lasted up to 4 h. Further studies examined the role of the mesolimbic dopamine system in the hyperactivity induced by MDMA. 6-Hydroxydopamine lesions of the Nucleus accumbens attenuated the locomotor response produced by MDMA. The well characterized attenuation of the locomotor response produced by amphetamine was also demonstrated in the same rats. The present study demonstrates similarities in the stimulant properties of MDMA and amphetamine, and also suggests that as with amphetamine, the locomotor activation associated with MDMA may involve the presynaptic release of dopamine in the region of the Nucleus accumbens. However, MDMA may have a more unusual pharmacological profile because of its longer duration of action, neurotoxic potential, and differences in the qualitative aspects of its psychoactive effects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571175     DOI: 10.1007/BF00634450

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  54 in total

1.  Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue.

Authors:  C J Schmidt; L Wu; W Lovenberg
Journal:  Eur J Pharmacol       Date:  1986-05-13       Impact factor: 4.432

2.  The relative importance of dopamine and norepinephrine in mediating locomotor activity.

Authors:  R H Fishman; J J Feigenbaum; J Yanai; H L Klawans
Journal:  Prog Neurobiol       Date:  1983       Impact factor: 11.685

3.  The pharmacological and anatomical substrates of the amphetamine response in the rat.

Authors:  I Creese; S D Iversen
Journal:  Brain Res       Date:  1975-01-17       Impact factor: 3.252

4.  Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

Authors:  D L Commins; G Vosmer; R M Virus; W L Woolverton; C R Schuster; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1987-04       Impact factor: 4.030

5.  Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.

Authors:  T D Steele; D E Nichols; G K Yim
Journal:  Biochem Pharmacol       Date:  1987-07-15       Impact factor: 5.858

6.  (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.

Authors:  D J Mokler; S E Robinson; J A Rosecrans
Journal:  Eur J Pharmacol       Date:  1987-06-19       Impact factor: 4.432

7.  Methysergide potentiates the hyperactivity produced by MDMA in rats.

Authors:  L H Gold; G F Koob
Journal:  Pharmacol Biochem Behav       Date:  1988-03       Impact factor: 3.533

8.  Discriminative profile of MDMA.

Authors:  M D Schechter
Journal:  Pharmacol Biochem Behav       Date:  1986-06       Impact factor: 3.533

9.  Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys.

Authors:  P M Beardsley; R L Balster; L S Harris
Journal:  Drug Alcohol Depend       Date:  1986-10       Impact factor: 4.492

10.  Lesions of central norepinephrine terminals with 6-OH-dopamine: biochemistry and fine structure.

Authors:  F E Bloom; S Algeri; A Groppetti; A Revuelta; E Costa
Journal:  Science       Date:  1969-12-05       Impact factor: 47.728

View more
  19 in total

1.  Decreased proliferation of adult hippocampal stem cells during cocaine withdrawal: possible role of the cell fate regulator FADD.

Authors:  M Julia García-Fuster; Shelly B Flagel; S Taha Mahmood; Leah M Mayo; Robert C Thompson; Stanley J Watson; Huda Akil
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

2.  Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.

Authors:  Kevin T Ball; George V Rebec
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

3.  The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists.

Authors:  Paul J Fletcher; Judy Sinyard; Guy A Higgins
Journal:  Psychopharmacology (Berl)       Date:  2006-07-11       Impact factor: 4.530

4.  Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine.

Authors:  David V Herin; Shijing Liu; Thomas Ullrich; Kenner C Rice; Kathryn A Cunningham
Journal:  Psychopharmacology (Berl)       Date:  2004-10-23       Impact factor: 4.530

Review 5.  Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Neuropharmacology       Date:  2011-01-20       Impact factor: 5.250

Review 6.  Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.

Authors:  M Isabel Colado; Esther O'Shea; A Richard Green
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

7.  Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioral sensitization in rats.

Authors:  María Ramos; Beatriz Goñi-Allo; Norberto Aguirre
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

8.  Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.

Authors:  C W Callaway; M P Johnson; L H Gold; D E Nichols; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain.

Authors:  Michael H Baumann; Robert D Clark; Richard B Rothman
Journal:  Pharmacol Biochem Behav       Date:  2008-03-04       Impact factor: 3.533

10.  Study of the behavioural responses related to the potential addictive properties of MDMA in mice.

Authors:  Patricia Robledo; Graciela Balerio; Fernando Berrendero; Rafael Maldonado
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.